DiObex Report issue

For profit Phase 1 Phase 3
Founded: San Francisco CA United States (2003)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2005
NCT00302224
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now